Transplantation of hematopoietic stem cells from bone marrow is a widely used method for treating various diseases, such as blood cancers, metabolic disorders, and autoimmune diseases. However, some patients are unable to undergo this procedure effectively due to problems with mobilizing an adequate number of stem cells. The study proposes to evaluate the role of […]

The project aims to investigate the role of proinsulin C-peptide and G-protein coupled receptor 146 (GPR146) in type 2 diabetes mellitus (T2DM) complications. C-peptide is a short peptide that influences multiple cellular pathways, and its role in diabetes complications has become increasingly evident. The study postulates that C-peptide interacts with the GPR146 receptor, which may […]

Colorectal cancer (CRC) is the second leading cause of cancer death in the world. Standard treatment of patients with locally advanced cancer of the rectum includes chemoradiotherapy (CHRT) before surgery. In recent years, the new standard of treatment for some patients with CRC has become immunotherapy with the use of so-called immune checkpoint inhibitors (ICI) […]

We are happy to announce that our team, as the part of international collaboration with UK FOCSS and Dana Farber Cancer Institute, was awarded the 2022 Bob Bast’s Translational Research Grant for the project entitled “Blood-based screening for identification and monitoring of women at elevated risk for breast and ovarian cancer”. The grant has been […]

We are pleased to announce that the members of our team – Arkadiusz Michalak (PhD student at the Department of Pediatrics, Diabetology, Endocrinology and Nephrology) and Aleksandra Ryk (PhD student at the Department of Biostatistics and Translational Medicine) were among the winners of the competition for research grants of the Polish Diabetes Association. Both PhD […]

We are happy to announce that Urszula Smyczyńska, PhD, MEng, has been awarded a research grant within MINIATURA 5 NCN call. The funds obtained will allow for 10-week research and training stay at Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA, during which our team member will investigate advanced image analysis techniques and their […]

The overall objective of this 5-year project is to build a multinational, adaptive European COVID-19 and emerging infectious diseases trial network, based on existing initiatives, experience and expertise, allowing European expansion of DisCoVeRy (WP1) and the establishment of a COVID19 adaptive platform trial (WP2). The DisCoVeRy trial, designed as a multi-arm adaptive repurposing trial, initiated […]

Wojciech Fendler, MD, PhD, Associate Professor carries out a project financed by a grant from the “OPUS 17” competition of the National Science Center. The human body exposed to high doses of radiation irreversibly loses the ability to produce circulating blood cells, which in a short time leads to death. This is due to multi-profile […]